Pub. Date : 1993 Nov
PMID : 8242759
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. | Tetradecanoylphorbol Acetate | Fc epsilon receptor II | Homo sapiens |
2 | The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. | Tetradecanoylphorbol Acetate | Fc epsilon receptor II | Homo sapiens |
3 | The expression of CD23 on human tonsillar B cells is increased following treatment with interleukin 4 (IL-4) or 12-O-tetradecanoylphorbol 13-acetate (TPA), while that of surface immunoglobulins (sIgs) is increased by IL-4 but decreased by TPA. | Tetradecanoylphorbol Acetate | Fc epsilon receptor II | Homo sapiens |
4 | In comparison, the up-regulation of CD23 by IL-4 and TPA was only partially blocked by these PKC inhibitors. | Tetradecanoylphorbol Acetate | Fc epsilon receptor II | Homo sapiens |
5 | TK inhibitors, such as herbimycin A and genistein, decreased both the IL-4- and TPA-induced CD23 expression by 50-80%, but had modest effects on sIgs expression. | Tetradecanoylphorbol Acetate | Fc epsilon receptor II | Homo sapiens |